S. 2003 · 115th Congress
FDA Cosmetic Safety and Modernization Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
HatchSponsorNo cosponsors.
This bill establishes a series of requirements relating to cosmetics regulation, including requiring cosmetics manufacturers and distributors to report serious adverse health events to the Food and Drug Administration.
What it does: CRS summary · Introduced in Senate · Oct 25, 2017
FDA Cosmetic Safety and Modernization Act
This bill establishes a series of requirements relating to cosmetics regulation, including requiring cosmetics manufacturers and distributors to report serious adverse health events to the Food and Drug Administration.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: FDA Cosmetic Safety and Modernization Act
Latest action (Oct 25, 2017): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Oct 25, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.